Cargando…

Cannabinoids in Medical Practice

Many patients with chronic medical illnesses use cannabinoids. There are two FDA-approved cannabinoid products, whereas medical marijuana purchased at legal dispensaries is not FDA regulated and may contain uncertain concentrations of various compounds. Cannabinoids have shown efficacy in treating c...

Descripción completa

Detalles Bibliográficos
Autor principal: Strouse, Thomas B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576598/
https://www.ncbi.nlm.nih.gov/pubmed/28861478
http://dx.doi.org/10.1089/can.2015.0010
_version_ 1783260211931250688
author Strouse, Thomas B.
author_facet Strouse, Thomas B.
author_sort Strouse, Thomas B.
collection PubMed
description Many patients with chronic medical illnesses use cannabinoids. There are two FDA-approved cannabinoid products, whereas medical marijuana purchased at legal dispensaries is not FDA regulated and may contain uncertain concentrations of various compounds. Cannabinoids have shown efficacy in treating chemotherapy-related nausea and vomiting, poor appetite in advanced HIV, some pain states, and multiple sclerosis-associated spasticity. Recreational cannabinoid use has many known potential serious harms. Physicians should be knowledgeable about cannabinoids and should inquire with their patients about cannabinoid use. Practical suggestions for clinical approaches are included.
format Online
Article
Text
id pubmed-5576598
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Mary Ann Liebert, Inc.
record_format MEDLINE/PubMed
spelling pubmed-55765982017-08-31 Cannabinoids in Medical Practice Strouse, Thomas B. Cannabis Cannabinoid Res Perspective Many patients with chronic medical illnesses use cannabinoids. There are two FDA-approved cannabinoid products, whereas medical marijuana purchased at legal dispensaries is not FDA regulated and may contain uncertain concentrations of various compounds. Cannabinoids have shown efficacy in treating chemotherapy-related nausea and vomiting, poor appetite in advanced HIV, some pain states, and multiple sclerosis-associated spasticity. Recreational cannabinoid use has many known potential serious harms. Physicians should be knowledgeable about cannabinoids and should inquire with their patients about cannabinoid use. Practical suggestions for clinical approaches are included. Mary Ann Liebert, Inc. 2016-01-01 /pmc/articles/PMC5576598/ /pubmed/28861478 http://dx.doi.org/10.1089/can.2015.0010 Text en © Thomas B. Strouse 2016; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Perspective
Strouse, Thomas B.
Cannabinoids in Medical Practice
title Cannabinoids in Medical Practice
title_full Cannabinoids in Medical Practice
title_fullStr Cannabinoids in Medical Practice
title_full_unstemmed Cannabinoids in Medical Practice
title_short Cannabinoids in Medical Practice
title_sort cannabinoids in medical practice
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576598/
https://www.ncbi.nlm.nih.gov/pubmed/28861478
http://dx.doi.org/10.1089/can.2015.0010
work_keys_str_mv AT strousethomasb cannabinoidsinmedicalpractice